| Stereochemistry | ABSOLUTE |
| Molecular Formula | C12H12Cl2N2O4 |
| Molecular Weight | 319.141 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2C=C(Cl)C(Cl)=C3
InChI
InChIKey=XHSQDZXAVJRBMX-DDHJBXDOSA-N
InChI=1S/C12H12Cl2N2O4/c13-5-1-7-8(2-6(5)14)16(4-15-7)12-11(19)10(18)9(3-17)20-12/h1-2,4,9-12,17-19H,3H2/t9-,10-,11-,12-/m1/s1
| Molecular Formula | C12H12Cl2N2O4 |
| Molecular Weight | 319.141 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 7.0 µM [IC50] | |||
| 18.0 µM [IC50] | |||
| 17.0 µM [IC50] |